Answer
Binimetinib in combination with encorafenib is indicated for adults with unresectable or metastatic melanoma with a BRAF V600 mutation.
Sources for this answer
- Mektovi 15 mg film-coated tabletsPierre Fabre Limited · emc · SmPC §4.1 Therapeutic Indications · Version 9Document updated
Sources checked